IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $126 | -28.4% | 14,542 | -5.6% | 0.00% | – |
Q4 2023 | $176 | +18.9% | 15,402 | +0.1% | 0.00% | – |
Q3 2023 | $148 | +111.4% | 15,391 | +132.8% | 0.00% | – |
Q2 2023 | $70 | +6900.0% | 6,612 | +5966.1% | 0.00% | – |
Q1 2023 | $1 | -99.3% | 109 | -99.0% | 0.00% | – |
Q4 2022 | $134 | -99.9% | 10,888 | -0.1% | 0.00% | – |
Q2 2022 | $125,000 | +60.3% | 10,900 | +73.8% | 0.00% | – |
Q1 2022 | $78,000 | +52.9% | 6,270 | +59.9% | 0.00% | – |
Q3 2021 | $51,000 | -94.2% | 3,921 | -94.9% | 0.00% | -100.0% |
Q4 2020 | $878,000 | +136.0% | 77,200 | +86.6% | 0.00% | 0.0% |
Q3 2020 | $372,000 | +332.6% | 41,379 | +384.8% | 0.00% | – |
Q1 2020 | $86,000 | +83.0% | 8,536 | +138.8% | 0.00% | – |
Q4 2019 | $47,000 | +291.7% | 3,574 | +142.6% | 0.00% | – |
Q3 2019 | $12,000 | – | 1,473 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $183,240,000 | 17.56% |
HealthInvest Partners AB | 1,450,000 | $16,211,000 | 12.91% |
Healthcare Value Capital, LLC | 200,000 | $2,236,000 | 4.98% |
BRIDGER MANAGEMENT, LLC | 2,852,414 | $31,890,000 | 2.98% |
Camber Capital Management LP | 7,500,000 | $83,850,000 | 2.88% |
13D Management LLC | 658,017 | $7,357,000 | 2.72% |
Brown Capital Management | 20,170,126 | $225,502,000 | 1.68% |
Healthcare Value Capital, LLC | 50,000 | $559,000 | 1.24% |
Zebra Capital Management LLC | 59,122 | $661,000 | 0.73% |
PRICE MICHAEL F | 520,000 | $5,814,000 | 0.70% |